thiazolyl blue has been researched along with Hepatitis C in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
de Ruiter, P; Janssen, HL; Kwekkeboom, J; Metselaar, HJ; Pan, Q; Tilanus, HW; van der Laan, LJ | 1 |
Cheng, G; Chisari, FV; Fredericksen, B; Gallay, PA; Gastaminza, P; Ghadiri, MR; Isogawa, M; Montero, A; Selvarajah, S; Whitten-Bauer, C; Wieland, SF | 1 |
2 other study(ies) available for thiazolyl blue and Hepatitis C
Article | Year |
---|---|
Calcineurin inhibitor tacrolimus does not interfere with the suppression of hepatitis C virus infection by interferon-alpha.
Topics: Antiviral Agents; Calcineurin Inhibitors; Cell Proliferation; Cell Survival; Gene Expression Regulation; Hepacivirus; Hepatitis C; Humans; Immunosuppressive Agents; Interferon-alpha; T-Lymphocytes; Tacrolimus; Tetrazolium Salts; Thiazoles | 2010 |
A virocidal amphipathic {alpha}-helical peptide that inhibits hepatitis C virus infection in vitro.
Topics: Amino Acid Sequence; Antiviral Agents; Cell Line; Circular Dichroism; Cytotoxicity Tests, Immunologic; Hepacivirus; Hepatitis C; Humans; In Vitro Techniques; Molecular Sequence Data; Peptides; Reverse Transcriptase Polymerase Chain Reaction; Structure-Activity Relationship; Tetrazolium Salts; Thiazoles; Virus Replication | 2008 |